BRD2 and neoplasm: Phosphoproteomics analysis identified 28,714 phosphosites including 21,088 (73.4%) on serine, 6836 (23.8%) on threonine, 790 (2.8%) on tyrosine; from 5964 phosphoproteins in 96 tumor samples, 22,776 phosphosites including 16,721 (73.4%) on serine, 5421 (23.8%) on threonine, 634 (2.8%) and on tyrosine, from 5147 phosphoproteins in 90 NAT samples (Supplementary Fig. S1e).